ADDERALL XR 10
LOE Approachingdextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate
NDAORALCAPSULE, EXTENDED RELEASE
Approved
Oct 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 4h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Adderall XR 10 is an extended-release oral capsule containing a mixture of amphetamine salts (dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate). It is a central nervous system stimulant indicated for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The drug works by increasing the release of norepinephrine and dopamine in the brain to improve focus, attention, and wakefulness.
LOE Approaching
As LOE approaches, the Adderall XR franchise is facing intensifying generic and competitive pressure; commercial team focus is shifting toward maximizing remaining exclusivity and defending market share against authorized generics and alternative therapies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Adderall XR as it approaches LOE requires expertise in defensive commercial strategy, generic competitor response, and lifecycle extension rather than growth-phase innovation. Career advancement is best pursued through roles emphasizing market access, prior authorization optimization, and transition planning to post-LOE portfolio roles.
Brand ManagerField Sales Representative
Worked on ADDERALL XR 10 at Takeda? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.